Financial Statement

Fiscal Year Ends	:	December
( in million Rupiah except Par Value, Per Share Data and Ratios )
Statement Date	:	2024-03-31
Balance Sheet
Cash & Cash Equivalents	:	19,333
Curr. Assets	:	172,335
Fixed Assets	:	189,727
Total Assets	:	362,062
Curr. Liabilities	:	80,129
Long Term Debt	:	53,367
Minority Interest	:	0
Total Liabilities	:	133,496
Paid-Up Capital	:	5,385
Total Equity	:	228,566
Income Statement
Total Sales	:	27,145
Gross Profit	:	18,148
Operating Profit	:	3,502
Net Income	:	2,163
Cash Flow Statement
Cash From Operating Act	:	-21,596
Cash From Investing Act	:	-3,585
Cash From Financing Act	:	3,797
Per Share Data (in IDR)
EPS	:	0.40
Book Value	:	42.44
Financial Ratios
Der	:	0.58
Roa	:	0.32
Roe	:	0.04
Npm	:	0.08
Opm	:	0.13
Growth Year to Year
Sales (%)	:	100.00%
Net Income (%)	:	100.00%
Total Assets (%) (%)	:	100.00%
Total Liabilities (%)	:	100.00%

1	RAK ICC Provides Strategic Solutions for Holding Companies and Regional Expansion

2	Illumina and PREMIA partner to expand clinical access to CGP in Asia

3	Rokid and Ant International Announce Integration of Smart Glasses Payment Capability

4	Salcomp's Debut on CES 2026

5	Call for Application for 2026 Tsinghua Amgen Scholars Program

RAK ICC Provides Strategic Solutions for Holding Companies and Regional Expansion